Methicillin-resistant Staphylococcus aureus
|
10.46%
|
10.01%
|
9.43%
|
8.77%
|
8.06%
|
7.48%
|
6.91%
|
6.64%
|
Vancomycin-resistant Enterococci
|
0.03%
|
0.05%
|
0.05%
|
0.03%
|
0.02%
|
0.02%
|
0.02%
|
0.02%
|
Penicillin-resistant
Streptococcus pneumoniae
|
1.31%
|
1.29%
|
1.38%
|
1.15%
|
0.89%
|
0.79%
|
0.69%
|
0.64%
|
Multidrug-resistant
Pseudomonas aeruginosa
|
0.23%
|
0.18%
|
0.18%
|
0.18%
|
0.14%
|
0.12%
|
0.09%
|
0.07%
|
Multidrug-resistant
Acinetobacter spp.
|
0.00%
|
0.00%
|
0.01%
|
0.01%
|
0.01%
|
0.01%
|
0.01%
|
0.01%
|
Carbapenem-resistant Enterobacteriaceae
|
ND
|
ND
|
ND
|
ND
|
ND
|
ND
|
0.49%
|
0.36%
|
Carbapenem-resistant
Pseudomonas aeruginosa
|
1.45%
|
1.30%
|
1.26%
|
1.26%
|
1.09%
|
0.98%
|
0.88%
|
0.84%
|
3rd generation cephalosporin-resistant Klebsiella pneumoniae
|
0.17%
|
0.18%
|
0.19%
|
0.24%
|
0.24%
|
0.23%
|
0.33%
|
0.32%
|
3rd generation cephalosporin-resistant Escherichia coli
|
0.62%
|
0.70%
|
0.86%
|
1.14%
|
1.30%
|
1.40%
|
1.82%
|
1.99%
|
Fluoroquinolone-resistant
Escherichia coli
|
1.79%
|
1.88%
|
2.15%
|
2.52%
|
2.87%
|
3.12%
|
3.35%
|
3.70%
|
Patients for whom samples were submitted
|
930,861
|
1,056,555
|
1,069,216
|
1,309,993
|
1,453,969
|
1,584,041
|
1,747,538
|
2,551,541
|